Lung cancer and epithelial-mesenchymal transition

Gen Thorac Cardiovasc Surg. 2021 May;69(5):781-789. doi: 10.1007/s11748-021-01595-4. Epub 2021 Mar 22.

Abstract

Lung cancer (LC) is a leading cause of cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) is a well-known phenomenon that promotes the invasive and metastatic capabilities of LC. Especially, EMT is assumed to be a pivotal mechanism for tumor cell invasion and metastasis, thereby limiting the efficacy of surgery and medical treatments, resulting in poor patient prognoses. Thus, the elucidation and reversal of EMT could provide changes in therapeutic strategies for LC. To overcome the limitations of currents treatment regimens for LC, it is important for surgeons to be familiar with this complex tumor characteristic. In this review, the activating signaling pathways underlying EMT and the associated tumor phenotypes are briefly described.

Keywords: Epithelial-mesenchymal transition; Invasion and metastasis; Lung cancer; Regulating mechanism.

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • Epithelial-Mesenchymal Transition*
  • Humans
  • Lung Neoplasms*
  • Neoplasm Invasiveness
  • Neoplasm Metastasis